SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-21-069747
Filing Date
2021-03-04
Accepted
2021-03-04 17:23:12
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC TO-C d226611dsctoc.htm SC TO-C 26884
2 EX-(A)(5)(B) d226611dex99a5b.htm EX-99.(A)(5)(B) 81761
3 EX-(A)(5)(C) d226611dex99a5c.htm EX-99.(A)(5)(C) 18361
  Complete submission text file 0001193125-21-069747.txt   128752
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filed by) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS, INC. (Subject) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-87623 | Film No.: 21715369
SIC: 2834 Pharmaceutical Preparations